Marksans Pharma share news, announcements and annual reports

NSE: MARKSANSBSE: 524404Pharmaceuticals & BiotechnologySmall Cap

Marksans Pharma Limited · Formerly Tasc Pharmaceuticals · Face value ₹1 · Listed Feb 1994 on BSE, Jan 2002 on NSE

₹306.20₹9.15 (2.90%)BSE ₹306.65

Share price at the NSE close on 30 Oct 2026. Previous close ₹315.35.

30 Oct: open ₹317.00, high ₹317.35, low ₹304.90

52-week range of traded prices to 30 Oct 2026

₹155.00Low, 30 Mar 2026₹350.95High, 24 Sep 2026

Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹13,876 Cr592nd largest listed
P/E: 26.85
P/B: 4.59
Dividend yield: 0.29%
ROE: 17.1%
ROCE: 19.9%
Debt to equity: 0.01
Volume, NSE: 12,10,63344.3% delivered

Marksans Pharma routine notices

136 filed, newest first. Page 3 of 3.

Feb 2022
- 14 Feb · Routine
  Copy of Newspaper Publication
Dec 2021
- 31 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Nov 2021
- 26 Nov · Routine
  Loss of Share Certificates
- 12 Nov · Routine
  Copy of Newspaper Publication
Sep 2021
- 30 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
- 30 Sep · Routine
  Loss of Share Certificates
- 1 Sep · Routine
  Notice of 29th AGM, Book closure and e-voting information published today i.e. 1st September, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
Aug 2021
- 31 Aug · Routine
  Loss of Share Certificates
- 16 Aug · Routine
  Copy of Newspaper Publication
- 12 Aug · Routine
  Copy of Newspaper Publication
- 4 Aug · Routine
  Loss of Share Certificates
Jul 2021
- 27 Jul · Routine
  Loss of Share Certificates
- 7 Jul · Routine
  Copy of Newspaper Publication
- 2 Jul · Routine
  We enclosed herewith a copy of Corrigendum to Notice of Extra-ordinary General Meeting of the Company published today i.e. 2nd July, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
Jun 2021
- 30 Jun · Routine
  We enclosed herewith copies of Notice given to shareholders regarding transfer of equity shares to the Investor Education and Protection Fund published today i.e. 30th June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
- 30 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
- 28 Jun · Routine
  Loss of Share Certificates
- 17 Jun · Routine
  We enclose herewith a copy of Notice in connection with Extra-ordinary General Meeting of the Company published today i.e. 17th June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
- 15 Jun · Routine
  We hereby furnish the details of loss of share certificate and request for issue of duplicate share certificate reported by one shareholder of our Company, received from our Registrar and Transfer Agent, Bigshare Services Private Limited on June 15, 2021.
- 1 Jun · Routine
  We enclosed herewith Financial Results of the Company for the financial year ended 31st March, 2021 published today i.e. 1st June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
May 2021
- 25 May · Routine
  Notice of the Board Meeting published today i.e. 25th May, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
Mar 2021
- 31 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
- 31 Mar · Routine
  We hereby furnish the details of loss of share certificates and request for issue of duplicate share certificate reported by shareholders of the Company, received from our Registrar and Transfer Agent, Bigshare Services Private Limited on March 30, 2021.
Feb 2021
- 9 Feb · Routine
  We enclose herewith a copy of unaudited financial results (standalone and Consolidated) for the quarter and nine months ended December 31, 2020 published in Business Standard (English) and Tarun Bharat (Marathi) newspapers.
Dec 2020
- 31 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Sep 2020
- 30 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, that the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed from Thursday, 1st October, 2020 till 48 hours after the declaration of financial results for the quarter and half-year ended 30th September, 2020. The date of declaration of financial results will be intimated separately in due course of time.
- 5 Sep · Routine
  30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice of 28th AGM, Book closure and e-voting information published today i.e. 5th September, 2020 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.
Aug 2020
- 27 Aug · Routine
  And in compliance with General Circular No.20/2020 dated May 5, 2020 issued by the Ministry of Corporate Affairs, we enclose herewith extract of newspaper advertisement published in Business Standard (English) and Tarun Bharat (Marathi) newspapers intimating, inter alia, 28th Annual General Meeting to be held on Tuesday, 29th September, 2020 at 11:00 a.m. through VC/ OAVM facility.
Jun 2020
- 30 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 that the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed with effect from Wednesday, 1st July, 2020 till 48 hours after the declaration of financial results for the quarter ended 30th June, 2020. The date of declaration of financial results will be intimated separately in due course of time.
Mar 2020
- 30 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 that trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed with effect from Wednesday, 1st April, 2020 till 48 hours after the declaration of financial results for the quarter and financial year ended 31st March, 2020. The date of declaration of financial results will be intimated separately in due course of time.
Jan 2020
- 2 Jan · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company has been closed with effect from Wednesday, 1st January, 2020 till 48 hours after the declaration of financial results for the quarter ended 31st December, 2019. The date of declaration of financial results will be intimated separately in due course of time.
Sep 2019
- 30 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Jun 2019
- 28 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. In terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading)(Amendment) Regulations, 2018, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed with effect from Monday, 1st July, 2019 till 48 hours after the declaration of financial results for the quarter ended 30th June, 2019. The date of declaration of financial results will be intimated separately in due course of time.Designated Persons, Employees and other insiders of the Company and/or their immediate relatives shall not trade in the securities of the Company during the aforesaid period of closure of trading window. You are requested to note the above in your records.
Apr 2019
- 3 Apr · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015In terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading)(Amendment) Regulations, 2018 and as per the clarification received from BSE and NSE vide their letters dated 2nd April, 2019, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) will remain closed with immediate effect (i.e. 3rd April, 2019) till 48 hours after the declaration of financial results for the quarter and year ended 31st March, 2019. The date of declaration of financial results will be intimated separately in due course of time.Employees of the Company and/or their immediate relatives shall not trade in the securities of the Company during the aforesaid period of closure of trading window.
Nov 2018
- 1 Nov · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. the Trading Window for dealing in Company's shares will remain closed for the Company's insiders from today i.e. 1st November, 2018 (Commencing from the time of above intimation to the Stock Exchanges) till Forty-Eight hours after the announcement of the Unaudited Financial Results on 13th November, 2018.
Nov 2016
- 4 Nov · Routine
  As per the Insider Trading Policy of the Company, Trading Window for dealing in Company s shares will remain closed for the Company s Insiders from November 4, 2016 (commencing from the time of above intimation to the Stock Exchanges) till 48 hours after the announcement of the second quarter financial results on November 12, 2016.

Marksans Pharma routine notices

Feb 2022

Dec 2021

Nov 2021

Sep 2021

Aug 2021

Jul 2021

Jun 2021

May 2021

Mar 2021

Feb 2021

Dec 2020

Sep 2020

Aug 2020

Jun 2020

Mar 2020

Jan 2020

Sep 2019

Jun 2019

Apr 2019

Nov 2018

Nov 2016